Foxconn Shrinks Plans for Wisconsin Plant 
 

The contract electronics maker signed a new deal with the state to invest as much as $672 million, instead of up to $10 billion.


 
Purdue's Sackler Family Owners Worth $11 Billion, Documents Show 
 

Summaries of the family wealth, turned over to Rep. Carolyn Maloney (D., N.Y.), also were seen by Purdue's creditors during settlement talks, according to representatives for the two branches of the company's family owners.


 
Apple's iPad and Mac Moment Should Linger 
 

The company's tablet and PC sales got a strong boost from the Covid-19 pandemic. Changes in work habits should keep demand elevated.


 
Meatpacker JBS USA Hires New Chief Legal Officer 
 

Beef and pork giant JBS USA Holdings has hired a former U.S. antitrust enforcer as its new chief legal officer, as the U.S. meat industry faces antitrust scrutiny.


 
Simon & Schuster Says Pence Book to Proceed, Despite Employee Petitions 
 

"We come to work each day to publish, not cancel," CEO Jonathan Karp said in a letter to staffers.


 
Tribune Publishing Sets Date for Shareholder Vote on Alden Bid 
 

The May 21 deadline narrows the window for competing bidder Stewart Bainum Jr. to firm up financing.


 
BHP Raises Fiscal Copper Guidance, Iron-Ore Output Falls 
 

BHP Group Ltd. said it would likely produce more copper than expected this fiscal year but less coal, as it reported a 4% fall in third-quarter iron-ore output because of bad weather and maintenance.


 
Regulator Bars Former Goldman Analyst for Insider Trading 
 

Finra says Brian Maguire bought shares in two companies after finding out about another analyst's upgrade.


 
SNC-Lavalin Says World Bank Lifts Sanctions Imposed in 2013 
 

SNC-Lavalin Group Inc. said Tuesday the World Bank Group has granted an early lifting of all sanctions imposed in 2013 against the Canadian engineering company.


 
J&J's Covid-19 Vaccine Adds $100 Million to Quarterly Sales 
 

In February the vaccine became the third shot to win emergency-use authorization from the FDA, but it is now on pause amid safety concerns.

(END) Dow Jones Newswires

04-20-21 2115ET